Bristol-Myers Squibb Co. believes it has made a ``full and fair offer'' to acquire full ownership of ImClone Systems Inc., a spokeswoman said Monday in response to ImClone's statement that the bid undervalues ImClone.
Bristol-Myers: 'have made a full and fair offer' for ImClone